Woody Sherman
PhD
Other Fields
Biotechnology, Leadership
Boston, Massachusetts, United States
Woody Sherman is CEO at Psivant Therapeutics. Prior roles included Chief Computational Scientist at Roivant Sciences, Chief Scientific Officer at Silicon Therapeutics, and Global Head of Applications Science at Schrodinger.
Woody received his B.S. in Physical Chemistry and B.A. in Creative Studies from the University of California at Santa Barbara. He then completed his Ph.D. at MIT working in Professor Bruce Tidor’s lab where he did research at the interface of physical chemistry, computer science, and drug design. While in graduate school he worked at Biogen where he developed a novel method to enhance antibody affinity via electrostatic charge optimization, resulting in a publication and patent. Then, as Global Head of Applications Science at Schrodinger, he led research, product development, methods development, and the deployment of Python-based tools. He also worked closely with Pharma partners on research projects and collaborations.
Woody has published over 100 peer-reviewed papers on a broad range of topics, including free energy simulations, molecular dynamics, machine learning, docking, protein design, small molecule optimization, cheminformatics, hybrid ligand/structure-based methods, charge optimization, pharmacophore modeling, and more. As CSO at Silicon Therapeutics, Woody was responsible for the development of computational methods and deployment in drug discovery projects. As Chief Computational Scientist at Roivant, Woody oversaw the development of the QUAISAR computational platform in addition to leading multiple drug discovery projects.
